Cibus completed U.S. FDA’s Plant Biotech Consultation program

Cibus (CBUS) announced that it has completed the U.S. Food and Drug Administration’s, FDA, Plant Biotechnology Consultation Program for its altered lignin alfalfa trait with the FDA notifying Cibus that it has no further questions concerning the use of altered lignin alfalfa in food or feed. To develop altered lignin alfalfa, Cibus collaborated with S&W Seed Company to identify an alfalfa trait with an altered lignin profile providing potential increased nutrient availability for livestock. This trait also gives farmers the added benefit of greater flexibility in harvest timing. The result is a higher value alfalfa produced on the same acre with the same inputs, putting greater profitability in the hands of the farmer.